Free vitamin D


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 15 03 2022
accepted: 12 05 2022
pubmed: 19 5 2022
medline: 19 7 2022
entrez: 18 5 2022
Statut: ppublish

Résumé

High levels of 25-hydroxyvitamin D A nested case-control study was performed with presymptomatic serum samples identified through cross-linkage of MS registries and Swedish biobanks. Concentration of 25(OH)D Serum samples from 660 pairs of matched cases and controls were included. At <20 years of age, high levels of free vitamin D These findings support the hypothesis that high levels of free 25(OH)D

Sections du résumé

BACKGROUND AND PURPOSE
High levels of 25-hydroxyvitamin D
METHODS
A nested case-control study was performed with presymptomatic serum samples identified through cross-linkage of MS registries and Swedish biobanks. Concentration of 25(OH)D
RESULTS
Serum samples from 660 pairs of matched cases and controls were included. At <20 years of age, high levels of free vitamin D
CONCLUSIONS
These findings support the hypothesis that high levels of free 25(OH)D

Identifiants

pubmed: 35582958
doi: 10.1111/ene.15407
pmc: PMC9545920
doi:

Substances chimiques

Vitamin D-Binding Protein 0
Vitamin D 1406-16-2
Cholecalciferol 1C6V77QF41

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2335-2342

Informations de copyright

© 2022 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.

Références

BMC Rheumatol. 2018 Sep 12;2:26
pubmed: 30886976
Neurology. 2011 Feb 8;76(6):540-8
pubmed: 21300969
J Alzheimers Dis. 2020;74(3):991-998
pubmed: 32116251
Neurology. 2012 Nov 20;79(21):2140-5
pubmed: 23170011
J Bone Miner Res. 2011 Jul;26(7):1609-16
pubmed: 21416506
Clin Chim Acta. 2006 Oct;372(1-2):33-42
pubmed: 16697362
Mult Scler. 2009 Apr;15(4):455-64
pubmed: 19324981
Mult Scler. 2014 Apr;20(4):433-7
pubmed: 23959712
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
Nutrients. 2019 Nov 15;11(11):
pubmed: 31731605
BMC Neurol. 2010 Nov 01;10:107
pubmed: 21040581
BMC Neurol. 2021 Apr 20;21(1):168
pubmed: 33879066
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:132-7
pubmed: 24095930
Circulation. 2019 May 21;139(21):2422-2436
pubmed: 30971107
Acta Neurol Scand Suppl. 2012;(195):90-6
pubmed: 23278663
Mult Scler J Exp Transl Clin. 2019 Dec 06;5(4):2055217319892291
pubmed: 31839980
Neurology. 2004 Jan 13;62(1):60-5
pubmed: 14718698
J Neuroimmunol. 2008 Feb;194(1-2):7-17
pubmed: 18177949
Neurol Genet. 2016 Sep 13;2(5):e97
pubmed: 27652346
J Immunol. 2012 Dec 1;189(11):5155-64
pubmed: 23087405
J Neuroimmunol. 2015 Feb 15;279:40-5
pubmed: 25669999
Toxins (Basel). 2015 Jan 13;7(1):129-37
pubmed: 25590278
J Neuroimmunol. 2013 Aug 15;261(1-2):134-40
pubmed: 23800457
Eur J Neurol. 2016 Jan;23(1):62-7
pubmed: 26220765
Nat Rev Neurol. 2012 Nov 5;8(11):602-12
pubmed: 23045241
Front Endocrinol (Lausanne). 2019 May 28;10:317
pubmed: 31191450
Eur J Neurol. 2022 Aug;29(8):2335-2342
pubmed: 35582958
J Immunol. 2013 Jul 15;191(2):848-56
pubmed: 23752613
Neurology. 2017 Oct 10;89(15):1578-1583
pubmed: 28904091
Cell Death Differ. 2013 Apr;20(4):630-8
pubmed: 23257976
BMC Immunol. 2014 Sep 18;15:35
pubmed: 25230725
Cell Mol Neurobiol. 2009 Mar;29(2):203-10
pubmed: 18807170
Mult Scler. 2018 Oct;24(12):1526-1535
pubmed: 30113253
Nat Rev Neurol. 2021 Aug;17(8):515-521
pubmed: 34155379
JAMA. 2006 Dec 20;296(23):2832-8
pubmed: 17179460
Front Endocrinol (Lausanne). 2020 Jan 10;10:910
pubmed: 31998239
PLoS One. 2013 Jun 07;8(6):e65184
pubmed: 23762311
J Clin Invest. 1981 Mar;67(3):589-96
pubmed: 6894152
Mol Immunol. 2006 Mar;43(8):1109-15
pubmed: 16115686
Best Pract Res Clin Endocrinol Metab. 2015 Oct;29(5):773-86
pubmed: 26522461

Auteurs

Viktor Grut (V)

Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.

Martin Biström (M)

Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.

Jonatan Salzer (J)

Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.

Pernilla Stridh (P)

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.

Anna Lindam (A)

Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Östersund Hospital, Umeå University, Umeå, Sweden.

Lucia Alonso-Magdalena (L)

Department of Neurology, Skåne University Hospital in Malmö/Lund and Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden.

Oluf Andersen (O)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Daniel Jons (D)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Martin Gunnarsson (M)

Department of Neurology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Magnus Vrethem (M)

Department of Neurology and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Johan Hultdin (J)

Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.

Peter Sundström (P)

Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH